Literature DB >> 29340515

[Illegitimate patients: Undocumented immigrants' access to health care in Chile].

Nanette Liberona Concha1, Miguel Ángel Mansilla2.   

Abstract

In recent decades, Chile has become a destination for immigrants from other South American countries, which has significantly impacted public services - particularly the public health system - at the economic, social, and cultural levels. The aim of this paper is to provide substantiated information on issues concerning undocumented immigrants' access to health care in Chile. A qualitative methodology, fundamentally an ethnography of the clinical setting, was used. Results were then analyzed in relation to theories of power asymmetries and interethnic relations. The research results highlight the lack of compliance with existing regulations and the exercise of discretionary personal judgment as barriers to access. It is concluded that in Chile immigrants in general, and undocumented immigrants in particular, are considered to be illegitimate patients.

Entities:  

Mesh:

Year:  2017        PMID: 29340515     DOI: 10.18294/sc.2017.1110

Source DB:  PubMed          Journal:  Salud Colect        ISSN: 1669-2381


  3 in total

1.  Indigenous Border Migrants and (Im)Mobility Policies in Chile in Times of COVID-19.

Authors:  Carlos Piñones-Rivera; Nanette Liberona; Rodrigo Arancibia; Verónica Jiménez
Journal:  Int J Environ Res Public Health       Date:  2022-08-07       Impact factor: 4.614

2.  How Do Health Teams Perceive International Migrant Users of Primary Care?

Authors:  Consuelo Cruz-Riveros; Alfonso Urzúa; Gustavo Macaya-Aguirre; Báltica Cabieses
Journal:  Int J Environ Res Public Health       Date:  2022-08-12       Impact factor: 4.614

3.  Individual and structural barriers to Latin American refugees and asylum seekers' access to primary and mental healthcare in Chile: A qualitative study.

Authors:  Alejandra Carreño-Calderón; Baltica Cabieses; M Eliana Correa-Matus
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.